Probiotic Agent
Probiotic Agent is a dietary supplement with 8 clinical trials. Currently 3 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
2
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
2 of 2 finished
0.0%
0 ended early
3
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Probiotic Use for Recovery Enhancement From Long COVID-19
Trial of Multi-Strain Probiotic Supplementation (Hexbio®) in Malaysian Patients With Drug-Resistant Epilepsy (ProbE)
Evaluation of the Effect of Streptococcus Salivarius K12 Probiotic in the Treatment of Periodontitis
Acute Immune Modulation by Probiotic Strain
Comparison of Probiotics, Metformin & Their Combination Therapy in the Treatment of PCOS
Clinical Trials (8)
Probiotic Use for Recovery Enhancement From Long COVID-19
Trial of Multi-Strain Probiotic Supplementation (Hexbio®) in Malaysian Patients With Drug-Resistant Epilepsy (ProbE)
Evaluation of the Effect of Streptococcus Salivarius K12 Probiotic in the Treatment of Periodontitis
Acute Immune Modulation by Probiotic Strain
Comparison of Probiotics, Metformin & Their Combination Therapy in the Treatment of PCOS
The Role of Dysbiosis of Gut Microbiota in the Pathogenesis of PCOS.
A New System for GERD Diagnosis and Treatment
Clinical Trial of Gut Microbiota in the Management of Immune Thrombocytopenia
All 8 trials loaded
Drug Details
- Intervention Type
- DIETARY SUPPLEMENT
- Total Trials
- 8